$1.62 Billion is the total value of ARMISTICE CAPITAL, LLC's 79 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TROV | Exit | TROVAGENE INC | $0 | – | -82,928 | -100.0% | -0.01% | – |
| EKSO | Exit | EKSO BIONICS HLDGS INC | $0 | – | -3,114,399 | -100.0% | -0.07% | – |
| Exit | ALIMERA SCIENCES INC | $0 | – | -340,000 | -100.0% | -0.15% | – | |
| TORC | Exit | RESTORBIO INC | $0 | – | -3,524,000 | -100.0% | -0.30% | – |
| OLLI | Exit | OLLIES BARGAIN OUTLT HLDGS I | $0 | – | -107,339 | -100.0% | -0.40% | – |
| KMX | Exit | CARMAX INC | $0 | – | -82,000 | -100.0% | -0.42% | – |
| DNKN | Exit | DUNKIN BRANDS GROUP INC | $0 | – | -98,000 | -100.0% | -0.43% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -20,000 | -100.0% | -0.43% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -37,000 | -100.0% | -0.44% | – |
| AYTU | Exit | AYTU BIOSCIENCE INC | $0 | – | -7,950,000 | -100.0% | -0.45% | – |
| TPR | Exit | TAPESTRY INC | $0 | – | -292,046 | -100.0% | -0.45% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -2,268,000 | -100.0% | -0.53% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -2,678,000 | -100.0% | -0.54% | – |
| BJ | Exit | BJS WHSL CLUB HLDGS INC | $0 | – | -475,746 | -100.0% | -0.62% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -128,000 | -100.0% | -0.65% | – |
| WBT | Exit | WELBILT INC | $0 | – | -724,000 | -100.0% | -0.65% | – |
| CPRI | Exit | CAPRI HOLDINGS LIMITED | $0 | – | -326,611 | -100.0% | -0.72% | – |
| KSS | Exit | KOHLS CORP | $0 | – | -250,000 | -100.0% | -0.74% | – |
| TJX | Exit | TJX COS INC NEW | $0 | – | -211,000 | -100.0% | -0.74% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -65,000 | -100.0% | -0.82% | – |
| ORLY | Exit | O REILLY AUTOMOTIVE INC NEW | $0 | – | -33,000 | -100.0% | -0.83% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -440,000 | -100.0% | -0.86% | – |
| RL | Exit | RALPH LAUREN CORPcl a | $0 | – | -152,168 | -100.0% | -1.03% | – |
| LULU | Exit | LULULEMON ATHLETICA INC | $0 | – | -83,700 | -100.0% | -1.12% | – |
| QSR | Exit | RESTAURANT BRANDS INTL INC | $0 | – | -312,850 | -100.0% | -1.15% | – |
| EL | Exit | LAUDER ESTEE COS INCcl a | $0 | – | -100,000 | -100.0% | -1.19% | – |
| NVST | Exit | ENVISTA HLDGS CORP | $0 | – | -848,000 | -100.0% | -1.45% | – |
| AZO | Exit | AUTOZONE INC | $0 | – | -24,651 | -100.0% | -1.69% | – |
| WSM | Exit | WILLIAMS SONOMA INC | $0 | – | -447,206 | -100.0% | -1.90% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.